However, different NMO-IgGs can have largedifferences in their ability to activate complement upon AQP4 binding, with someepitopes more facilitative for IgG hexamerization, meaning that there is not asimple relationship between antibody titre and disease severity.108. This evidence concerns the gene AQP4 and neuromyelitis optica.